![A new study found that people with type 2 diabetes who were being treated with a class of GLP-1 drugs were significantly less likely to be diagnosed with 10 of the 13 obesity-associated cancers.](https://abc17news.b-cdn.net/abc17news.com/2024/07/cnn-L19jb21wb25lbnRzL2ltYWdlL2luc3RhbmNlcy9jbHk5ZTVtd3cwMDAwM2I2bHZrM250Z2oz-L19jb21wb25lbnRzL2FydGljbGUvaW5zdGFuY2VzL2NseTk5d3A4bTAwMHc4bHAxMW9oaTl6eTU-375x225.jpg)
Popular weight-loss and diabetes medications linked to lower risk of some cancers, study finds
By Deidre McPhillips, CNN (CNN) — GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests. People who are overweight or obese have a higher risk of getting 13 types of cancer, and the risk increases the longer a person is overweight and the more excess
Continue Reading